Takotsubo Cardiomyopathy in the Setting of Hypertrophic Cardiomyopathy Following Pacemaker Implantation

George Boghdadi1, Emmanuel Bassily2

  • 1Internal Medicine, George Washington School of Medicine & Health Sciences, Washington DC, USA.

Cureus
|May 1, 2023
PubMed

Insights

Takotsubo cardiomyopathy (TC) can mimic acute coronary syndrome (ACS). This case highlights an increased risk of TC in patients with hypertrophic cardiomyopathy (HCM) undergoing pacemaker placement.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Cardiac Electrophysiology

Background:

  • Takotsubo cardiomyopathy (TC) shares clinical and echocardiographic features with acute coronary syndrome (ACS).
  • TC is often triggered by emotional or physical stress and is linked to various comorbidities.
  • Hypertrophic cardiomyopathy (HCM) is associated with heightened cardiac sympathetic activity.

Observation:

  • A 73-year-old female with known hypertrophic obstructive cardiomyopathy (HOCM) presented with high-degree atrioventricular (AV) block.
  • The patient required permanent pacemaker (PPM) implantation for the AV block.
  • Following PPM placement, the patient developed Takotsubo cardiomyopathy (TC).

Findings:

  • This case illustrates a multifactorial presentation of TC in a patient with underlying HOCM.
  • The study suggests a potential increased susceptibility to TC in HOCM patients during procedures like PPM placement.
  • The interplay between HOCM, autonomic dysfunction, and iatrogenic stress is implicated.

Implications:

  • Recognizing the heightened risk of TC in HOCM patients undergoing cardiac procedures is crucial for early diagnosis and management.
  • Further research is warranted to elucidate the mechanisms linking HOCM, autonomic nervous system activity, and TC development.
  • This case underscores the importance of considering TC in the differential diagnosis of new-onset cardiac dysfunction in susceptible populations.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
18
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
26
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
13
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
18
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
13